ConTIPI Medical Ltd

ConTIPI Medical provides non-surgical and disposable vaginal solutions for women with various Pelvic Floor Disorders (PFD's). ConTIPI Medical's vaginal solutions follow a specific concept allowing women to manage their condition directly. This concept has already proved itself, brought from a design into a mature product in the market. The Impressa Device for Stress Urinary Incontinence, bought by Kimberly Clark Worldwide Inc, is marketed by Kimberly Clark Inc. under its Poise® brand (http://www.impressapro.com). ConTIPI Medical's second product, the ProVate Device, intended for the non-surgical management of Pelvic Organ Prolapse (POP) has a CE Mark for marketing in the EU and is currently within final clinical studies in the USA (considered an investigational device, limited by Federal law to investigational use). Each device comes ready for use within a wrapper, to be used by the user herself in the comfort of her home. The devices are inserted vaginally, compressed to small dimensions inside an applicator. Within the vagina, the applicator deploys the device and it opens to provide support to pre-defined specific sites along the vaginal walls. At the end of usage, the device is removed by a pull of a string, which also causes it to considerably diminish in size, and is disposed. Such devices allow women to take control over their medical problems and use them in privacy and at their convenience. ProVate device: Most women with Pelvic Organ Prolapse will only require non-invasive management. Existing pessaries are associated with high discontinuation rate, and with high rate of reluctance to use a reusable device which is difficult for most users to insert and remove. The ProVate disposable device was designed to provide vaginal support, inserted and removed by the user at her home.

• Employees 4
• Founded 2014
• Total Funding $54000000